Iovance Biotherapeutics: TD Cowen raises target price to $16 from $10
IOVA•TD Cowen raised its target price for Iovance Biotherapeutics to $16 from $10.
Related News
Northrop Grumman wins $18.8 million US Army contract for extended-range counter-drone missile work
NOC•
ISS National Lab says NASA's SpaceX Crew-13 mission will launch no earlier than October 1
SPCE•
KKR signs majority investment in India’s Cisternina Logistics
KKR•
Visa joins growing alarm over AI-powered risks
V•
Oracle gains as OpenAI reportedly nears $70 billion ARR
ORCL•